Barendregt DMH, Tuk B, Hulleman-van Haaften DH, Camman AE, et al. Plasma lipopolysaccharide-binding protein (LBP), a proxy for intestinal
permeability, relates to clinicopathological and immunological disease activity
in inflammatory bowel disease patients at diagnosis and during disease course. J Crohns Colitis 2026;20:jjag146.
PMID: 42854107
|